The Factors Related to CD4+ T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+ T Cell Counts at the Initiation of HAART: A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province, China, 2014
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference46 articles.
1. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study;F Zhang;Lancet Infect Dis,2011
2. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach,2013
3. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy;RS Hogg;JAMA,2001
4. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000–2004);TR Chadborn;AIDS,2006
5. Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery;FN Engsig;Clin Infect Dis,2014
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Trends and the associated factors of optimal immunological response and virological response in late anti-retroviral therapy initiation HIV cases in Taiwan from 2009 to 2020;Journal of Infection and Public Health;2024-02
2. Pattern of CD4 + T cell recovery and determinants of HIV infected individuals receiving highly active antiretroviral treatment in Mekelle Hospital, Tigray Northern Ethiopia; Retrospective study;2023-01-19
3. High baseline body mass index predicts recovery of CD4+ T lymphocytes for HIV/AIDS patients receiving long-term antiviral therapy;PLOS ONE;2022-12-30
4. The pattern and magnitude of T cell subsets reconstitution during ten years of ART with viral suppression in HIV-infected patients;Aging;2022-12-09
5. Efficacy and safety of Efavirenz 400 mg-based regimens switching from 600 mg-based regimens in people living with HIV with virological suppression in China: a randomized, open-label, non-inferiority study;International Journal of Infectious Diseases;2022-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3